Citations (70)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Deepak Menon, Alejandra Urra Pincheira & Vera Bril. (2021) Emerging drugs for the treatment of myasthenia gravis. Expert Opinion on Emerging Drugs 26:3, pages 259-270.
Read now
Read now
Harbani K. Malik-Chaudhry, Kirthana Prabhakar, Harshad S. Ugamraj, Andrew A. Boudreau, Benjamin Buelow, Kevin Dang, Laura M. Davison, Katherine E. Harris, Brett Jorgensen, Heather Ogana, Duy Pham, Ute Schellenberger, Wim Van Schooten, Roland Buelow, Suhasini Iyer, Nathan D. Trinklein & Udaya S. Rangaswamy. (2021) TNB-486 induces potent tumor cell cytotoxicity coupled with low cytokine release in preclinical models of B-NHL. mAbs 13:1.
Read now
Read now
Eric Hatterer, Leticia Barba, Nelly Noraz, Bruno Daubeuf, Jean-Pierre Aubry-Lachainaye, Benoit von der Weid, Françoise Richard, Marie Kosco-Vilbois, Walter Ferlin, Limin Shang & Vanessa Buatois. (2019) Co-engaging CD47 and CD19 with a bispecific antibody abrogates B-cell receptor/CD19 association leading to impaired B-cell proliferation. mAbs 11:2, pages 322-334.
Read now
Read now
Mauro Alaibac. (2019) Biological therapy of autoimmune blistering diseases. Expert Opinion on Biological Therapy 19:2, pages 149-156.
Read now
Read now
Bharath Wootla, Jens O. Watzlawik, Nikolaos Stavropoulos, Nathan J. Wittenberg, Harika Dasari, Murtada A. Abdelrahim, John R. Henley, Sang-Hyun Oh, Arthur E. Warrington & Moses Rodriguez. (2016) Recent Advances in Monoclonal Antibody Therapies for Multiple Sclerosis. Expert Opinion on Biological Therapy 16:6, pages 827-839.
Read now
Read now
Emanuele D’Amico, Cinzia Caserta & Francesco Patti. (2015) Monoclonal antibody therapy in multiple sclerosis: critical appraisal and new perspectives. Expert Review of Neurotherapeutics 15:3, pages 251-268.
Read now
Read now
Mark R Litzow. (2014) Antigen-based immunotherapy for the treatment of acute lymphoblastic leukemia: the emerging role of blinatumomab. ImmunoTargets and Therapy 3, pages 79-89.
Read now
Read now
Articles from other publishers (63)
Mahmoud Ganji, Pooria Safarzadeh Kozani & Fatemeh Rahbarizadeh. (2023) Characterization of novel CD19-specific VHHs isolated from a camelid immune library by phage display. Journal of Translational Medicine 21:1.
Crossref
Crossref
Christopher C. Marvin, Adrian D. Hobson, Michael McPherson, Theresa A. Dunstan, Thomas R. Vargo, Martin E. Hayes, Margaret M. Fettis, Agnieszka Bischoff, Lu Wang, Lu Wang, Axel HernandezJr.Jr., Ying Jia, Jason Z. Oh & Yu Tian. (2023) Self-Immolative Carbamate Linkers for CD19-Budesonide Antibody–Drug Conjugates. Bioconjugate Chemistry 34:10, pages 1835-1850.
Crossref
Crossref
Dong-Ho Nahm. (2023) Regulatory T Cell-Targeted Immunomodulatory Therapy for Long-Term Clinical Improvement of Atopic Dermatitis: Hypotheses and Perspectives. Life 13:8, pages 1674.
Crossref
Crossref
Maria Patra-Kneuer, Gaomei Chang, Wendan Xu, Christian Augsberger, Michael Grau, Myroslav Zapukhlyak, Kristina Ilieva, Karin Landgraf, Doris Mangelberger-Eberl, Kasra Yousefi, Philipp Berning, Katrin S. Kurz, German Ott, Pavel Klener, Cyrus Khandanpour, Pedro Horna, Jürgen Schanzer, Stefan Steidl, Jan Endell, Christina Heitmüller & Georg Lenz. (2023) Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphoma. Frontiers in Immunology 14.
Crossref
Crossref
Max Topp, Monika Dlugosz-Danecka, Aleksander B. Skotnicki, Galina Salogub, Andreas Viardot, Andreas K. Klein, Georg Hess, Christian S. Michel, Sebastian Grosicki, Alex Gural, Sylvia E. Schwarz, Kerstin Pietzko, Ulrike Gärtner, András Strassz, Leila Alland & Jiri Mayer. (2023) Safety of AFM11 in the treatment of patients with B-cell malignancies: findings from two phase 1 studies. Trials 24:1.
Crossref
Crossref
Salwan Al Hani, Sarah Provencher, Ryan Ko, Sarah Lerchenfeldt, Claudio Cortes & Kyeorda Kemp. 2022. Handbook of Cancer and Immunology. Handbook of Cancer and Immunology
1
48
.
Ankur Kaushal, Narinder Kaur, Surbhi Sharma, Anil Sharma, Deepak Kala, Hridayesh Prakash & Shagun Gupta. (2022) Current Update on Biomarkers for Detection of Cancer: Comprehensive Analysis. Vaccines 10:12, pages 2138.
Crossref
Crossref
Prajjwol Luitel, Anup Ghimire, Devansh Upadhyay & Rajeev Ojha. (2022) Efficacy of monoclonal antibodies in neuromyelitis optica: An updated systematic review with meta‐analysis. Clinical and Experimental Neuroimmunology 13:4, pages 194-207.
Crossref
Crossref
Sarah Bailly, Guillaume Cartron, Sridhar Chaganti, Raul Córdoba, Paolo Corradini, Johannes Düll, Isacco Ferrarini, Wendy Osborne, Andreas Rosenwald, Juan‐Manuel Sancho, Hervé Tilly, Eric Van Den Neste, Andreas Viardot & Carlo Visco. (2022) Targeting CD19 in diffuse large B‐cell lymphoma: An expert opinion paper. Hematological Oncology 40:4, pages 505-517.
Crossref
Crossref
Carina Lynn Gehlert, Pegah Rahmati, Ammelie Svea Boje, Dorothee Winterberg, Steffen Krohn, Thomas Theocharis, Elisa Cappuzzello, Anja Lux, Falk Nimmerjahn, Ralf J. Ludwig, Marta Lustig, Thies Rösner, Thomas Valerius, Denis Martin Schewe, Christian Kellner, Katja Klausz & Matthias Peipp. (2022) Dual Fc optimization to increase the cytotoxic activity of a CD19-targeting antibody. Frontiers in Immunology 13.
Crossref
Crossref
Michael Boettcher, Alexander Joechner, Ziduo Li, Sile Fiona Yang & Patrick Schlegel. (2022) Development of CAR T Cell Therapy in Children—A Comprehensive Overview. Journal of Clinical Medicine 11:8, pages 2158.
Crossref
Crossref
Marie-Kristin Tilch, Tadeusz Robak, Chiara Ghiggi, Elke Wuff, Stephanie Herold, Matthias Theobald & Georg Hess. (2022) Safety of the Anti-CD19 antibody Tafasitamab in Long Term Responders from A Phase II Trial for Relapsed Lymphoma. Clinical Lymphoma Myeloma and Leukemia 22:4, pages 270-275.
Crossref
Crossref
Vyanka Redenbaugh & Eoin P. Flanagan. (2022) Monoclonal Antibody Therapies Beyond Complement for NMOSD and MOGAD. Neurotherapeutics 19:3, pages 808-822.
Crossref
Crossref
Julia Dahlke, Juliane W. Schott, Philippe Vollmer Barbosa, Denise Klatt, Anton Selich, Nico Lachmann, Michael Morgan, Thomas Moritz & Axel Schambach. (2021) Efficient Genetic Safety Switches for Future Application of iPSC-Derived Cell Transplants. Journal of Personalized Medicine 11:6, pages 565.
Crossref
Crossref
Dorothee Winterberg, Lennart Lenk, Maren Oßwald, Fotini Vogiatzi, Carina Lynn Gehlert, Fabian-Simon Frielitz, Katja Klausz, Thies Rösner, Thomas Valerius, Anna Trauzold, Matthias Peipp, Christian Kellner & Denis Martin Schewe. (2021) Engineering of CD19 Antibodies: A CD19-TRAIL Fusion Construct Specifically Induces Apoptosis in B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Cells In Vivo. Journal of Clinical Medicine 10:12, pages 2634.
Crossref
Crossref
Mehdi Hamadani, John Radford, Carmelo Carlo-Stella, Paolo F. CaimiErin Reid, Owen A. O’ConnorJay M. FeingoldKirit M. ArdeshnaWilliam TownsendMelhem SolhLeonard T. HeffnerDavid UngarLuqiang WangJoseph BoniKarin Havenith, Yajuan QinBrad S. Kahl. (2021) Final results of a phase 1 study of loncastuximab tesirine in relapsed/refractory B-cell non-Hodgkin lymphoma. Blood 137:19, pages 2634-2645.
Crossref
Crossref
Dean G. Brown & Heike J. Wobst. (2021) A Decade of FDA-Approved Drugs (2010–2019): Trends and Future Directions. Journal of Medicinal Chemistry 64:5, pages 2312-2338.
Crossref
Crossref
Krishna Goparaju, Allison Winter & Paolo F Caimi. (2021) The Anti-CD19 Antibody-Drug Conjugate Loncastuximab Tesirine. Oncology & Haematology 17:2, pages 95.
Crossref
Crossref
Tanja Fetter, Dennis Niebel, Christine Braegelmann & Joerg Wenzel. (2020) Skin-Associated B Cells in the Pathogenesis of Cutaneous Autoimmune Diseases—Implications for Therapeutic Approaches. Cells 9:12, pages 2627.
Crossref
Crossref
Sophia Roßkopf, Klara Marie Eichholz, Dorothee Winterberg, Katarina Julia Diemer, Sebastian Lutz, Ira Alexandra Münnich, Katja Klausz, Thies Rösner, Thomas Valerius, Denis Martin Schewe, Andreas Humpe, Martin Gramatzki, Matthias Peipp & Christian Kellner. (2020) Enhancing CDC and ADCC of CD19 Antibodies by Combining Fc Protein-Engineering with Fc Glyco-Engineering. Antibodies 9:4, pages 63.
Crossref
Crossref
Wenli Zhu, Yaling Zhang, Zhen Wang, Ying Fu & Yaping Yan. (2020) Monoclonal Antibody-Based Treatments for Neuromyelitis Optica Spectrum Disorders: From Bench to Bedside. Neuroscience Bulletin 36:10, pages 1213-1224.
Crossref
Crossref
Deepak Menon, Carolina Barnett & Vera Bril. (2020) Novel Treatments in Myasthenia Gravis. Frontiers in Neurology 11.
Crossref
Crossref
Margaux Lejeune, Murat Cem Köse, Elodie Duray, Hermann Einsele, Yves Beguin & Jo Caers. (2020) Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies. Frontiers in Immunology 11.
Crossref
Crossref
Nooshafarin Amani, Farid Abedin Dorkoosh & Hamid Mobedi. (2020) ADCs, as Novel Revolutionary Weapons for Providing a Step Forward in Targeted Therapy of Malignancies. Current Drug Delivery 17:1, pages 23-51.
Crossref
Crossref
Jonas Y. Lee, Khue Dang, Alan Liu & Benjamin M. Alba. (2020) Automated buffer preparation using quaternary valve in fast performance liquid chromatography for protein purification from a cell membrane. Journal of Chromatography B 1136, pages 121849.
Crossref
Crossref
Brad S. Kahl, Mehdi Hamadani, John Radford, Carmelo Carlo-Stella, Paolo Caimi, Erin Reid, Jay M. Feingold, Kirit M. Ardeshna, Melhem Solh, Leonard T. Heffner, David Ungar, Shui He, Joseph Boni, Karin Havenith & Owen A. O'Connor. (2019) A Phase I Study of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody–Drug Conjugate, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma. Clinical Cancer Research 25:23, pages 6986-6994.
Crossref
Crossref
. (2019) Issue Highlights – July 2019. Cytometry Part B: Clinical Cytometry 96:4, pages 253-255.
Crossref
Crossref
Tetsuo Tsukamoto. (2019) Gene Therapy Approaches to Functional Cure and Protection of Hematopoietic Potential in HIV Infection. Pharmaceutics 11:3, pages 114.
Crossref
Crossref
Darsheen J. Kotak, Pooja A. Todke, Prajakta Dandekar & Padma V. Devarajan. 2019. Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis. Targeted Intracellular Drug Delivery by Receptor Mediated Endocytosis
383
406
.
Sisi LiDiying ShenXiaoping GuoChan LiaoYongmin Tang. (2018) Construction, Expression, and Characterization of a Novel Human–Mouse Chimeric Antibody, Hm3A4: A Potential Therapeutic Agent for B and Myeloid Lineage Leukemias. DNA and Cell Biology 37:9, pages 778-785.
Crossref
Crossref
Zhuanglin Li, Mingxue Wang, Xuejing Yao, Huanzhao Li, Shenjun Li, Lina Liu, Deling Yu, Xue Li, Jianmin Fang & Changjiang Huang. (2018) Development of novel anti-CD19 antibody-drug conjugates for B-cell lymphoma treatment. International Immunopharmacology 62, pages 299-308.
Crossref
Crossref
Elaine Vickers. 2018. A Beginner's Guide to Targeted Cancer Treatments. A Beginner's Guide to Targeted Cancer Treatments
259
312
.
Alexey Teplyakov, Galina Obmolova, Jinquan Luo & Gary L. Gilliland. (2018) Crystal structure of B-cell co-receptor CD19 in complex with antibody B43 reveals an unexpected fold. Proteins: Structure, Function, and Bioinformatics 86:5, pages 495-500.
Crossref
Crossref
Katharina Hofmann, Ann-Katrin Clauder & Rudolf Armin Manz. (2018) Targeting B Cells and Plasma Cells in Autoimmune Diseases. Frontiers in Immunology 9.
Crossref
Crossref
Rashmi Kumar. 2018. Encyclopedia of Signaling Molecules. Encyclopedia of Signaling Molecules
513
522
.
Hélène Jakobczyk, Flavien Sciortino, Soizic Chevance, Fabienne Gauffre & Marie-Bérengère Troadec. (2017) Promises and limitations of nanoparticles in the era of cell therapy: Example with CD19-targeting chimeric antigen receptor (CAR)-modified T cells. International Journal of Pharmaceutics 532:2, pages 813-824.
Crossref
Crossref
Anjali S. Advani. (2017) “MOR” engineering of antibodies in ALL. Blood 130:13, pages 1487-1488.
Crossref
Crossref
Denis M. Schewe, Ameera Alsadeq, Cornelia Sattler, Lennart Lenk, Fotini Vogiatzi, Gunnar Cario, Simon Vieth, Thomas Valerius, Sophia Rosskopf, Fabian Meyersieck, Julia Alten, Martin Schrappe, Martin Gramatzki, Matthias Peipp & Christian Kellner. (2017) An Fc-engineered CD19 antibody eradicates MRD in patient-derived MLL-rearranged acute lymphoblastic leukemia xenografts. Blood 130:13, pages 1543-1552.
Crossref
Crossref
Alice Cho, Bridget Bradley, Robert Kauffman, Lalita Priyamvada, Yevgeniy Kovalenkov, Ron Feldman & Jens Wrammert. (2017) Robust memory responses against influenza vaccination in pemphigus patients previously treated with rituximab. JCI Insight 2:12.
Crossref
Crossref
Xiaojie Yu, Michael J. E. Marshall, Mark S. Cragg & Max Crispin. (2017) Improving Antibody-Based Cancer Therapeutics Through Glycan Engineering. BioDrugs 31:3, pages 151-166.
Crossref
Crossref
Liqin Liu, Chia-Ying K. Lam, Vatana Long, Lusiana Widjaja, Yinhua Yang, Hua Li, Linda Jin, Steve Burke, Sergey Gorlatov, Jennifer Brown, Ralph Alderson, Margaret D. Lewis, Jeffrey L. Nordstrom, Scott Koenig, Paul A. Moore, Syd Johnson & Ezio Bonvini. (2017) MGD011, A CD19 x CD3 Dual-Affinity Retargeting Bi-specific Molecule Incorporating Extended Circulating Half-life for the Treatment of B-Cell Malignancies. Clinical Cancer Research 23:6, pages 1506-1518.
Crossref
Crossref
Xiaohu Zheng, Xiaolei Fan, Binqing Fu, Meijuan Zheng, Aimei Zhang, Kai Zhong, Jialai Yan, Rui Sun, Zhigang Tian & Haiming Wei. (2017) EpCAM Inhibition Sensitizes Chemoresistant Leukemia to Immune Surveillance. Cancer Research 77:2, pages 482-493.
Crossref
Crossref
Christian B. Schiller, Todd A. Braciak, Nadja C. Fenn, Ursula J. E. Seidel, Claudia C. Roskopf, Sarah Wildenhain, Annemarie Honegger, Ingo A. Schubert, Alexandra Schele, Kerstin Lämmermann, Georg H. Fey, Uwe Jacob, Peter Lang, Karl-Peter Hopfner & Fuat S. Oduncu. (2016) CD19-specific triplebody SPM-1 engages NK and γδ T cells for rapid and efficient lysis of malignant B-lymphoid cells. Oncotarget 7:50, pages 83392-83408.
Crossref
Crossref
Thaís Armangue, Anusha K. Yeshokumar, Maria Sepúlveda, Francesc Graus & Albert Saiz. (2016) Antibodies in acquired demyelinating disorders in children. Multiple Sclerosis and Demyelinating Disorders 1:1.
Crossref
Crossref
Wojciech Jurczak, Agata Hanna Bryk, Patrycja Mensah, Krystyna Gałązka, Małgorzata Trofimiuk–Müldner, Łukasz Wyrobek, Anna Sawiec & Aleksander B. Skotnicki. (2016) Single-agent MOR208 salvage and maintenance therapy in a patient with refractory/relapsing diffuse large B-cell lymphoma: a case report. Journal of Medical Case Reports 10:1.
Crossref
Crossref
Ding Chen, Sandra Gallagher, Nancy Monson, Ronald Herbst & Yue Wang. (2016) Inebilizumab, a B Cell-Depleting Anti-CD19 Antibody for the Treatment of Autoimmune Neurological Diseases: Insights from Preclinical Studies. Journal of Clinical Medicine 5:12, pages 107.
Crossref
Crossref
Ursula Jördis Eva Seidel, Patrick Schlegel, Ludger Grosse-Hovest, Martin Hofmann, Steffen Aulwurm, Elwira Pyz, Friedhelm R Schuster, Roland Meisel, Martin Ebinger, Tobias Feuchtinger, Heiko-Manuel Teltschik, Kai-Erik Witte, Carl-Philipp Schwarze, Hans-Georg Rammensee, Rupert Handgretinger, Gundram Jung & Peter Lang. (2016) Reduction of Minimal Residual Disease in Pediatric B-lineage Acute Lymphoblastic Leukemia by an Fc-optimized CD19 Antibody. Molecular Therapy 24:9, pages 1634-1643.
Crossref
Crossref
Sean J. Pittock & Claudia F. Lucchinetti. (2016) Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later. Annals of the New York Academy of Sciences 1366:1, pages 20-39.
Crossref
Crossref
Shannon R. Hinson, Vanda A. Lennon & Sean J. Pittock. 2016. Autoimmune Neurology. Autoimmune Neurology
377
403
.
Manzoor M KhanManzoor M. Khan. 2016. Immunopharmacology. Immunopharmacology
397
425
.
Rashmi Kumar. 2017. Encyclopedia of Signaling Molecules. Encyclopedia of Signaling Molecules
1
10
.
Elena Sherman & May H. Han. (2015) Acute and Chronic Management of Neuromyelitis Optica Spectrum Disorder. Current Treatment Options in Neurology 17:11.
Crossref
Crossref
Wildéa Lice de Carvalho Jennings Pereira, Edna Maria Vissoci Reiche, Ana Paula Kallaur & Damacio Ramón Kaimen-Maciel. (2015) Epidemiological, clinical, and immunological characteristics of neuromyelitis optica: A review. Journal of the Neurological Sciences 355:1-2, pages 7-17.
Crossref
Crossref
Judith Weiland, Alex Elder, Victoria Forster, Olaf Heidenreich, Steffen Koschmieder & Josef Vormoor. (2015) CD19: A multifunctional immunological target molecule and its implications for Blineage acute lymphoblastic leukemia. Pediatric Blood & Cancer 62:7, pages 1144-1148.
Crossref
Crossref
Tadeusz Robak & Pawel Robak. 2015. Resistance to Immunotoxins in Cancer Therapy. Resistance to Immunotoxins in Cancer Therapy
89
128
.
Ursula Jördis Eva Seidel, Fabian Vogt, Ludger Grosse-Hovest, Gundram Jung, Rupert Handgretinger & Peter Lang. (2014) γδ T Cell-Mediated Antibody-Dependent Cellular Cytotoxicity with CD19 Antibodies Assessed by an Impedance-Based Label-Free Real-Time Cytotoxicity Assay. Frontiers in Immunology 5.
Crossref
Crossref
Marios C. Papadopoulos, Jeffrey L. Bennett & Alan S. Verkman. (2014) Treatment of neuromyelitis optica: state-of-the-art and emerging therapies. Nature Reviews Neurology 10:9, pages 493-506.
Crossref
Crossref
Markus C. Kowarik, John Soltys & Jeffrey L. Bennett. (2014) The Treatment of Neuromyelitis Optica. Journal of Neuro-Ophthalmology 34:1, pages 70-82.
Crossref
Crossref
Hannah Byrne, Paul J. Conroy, James C. Whisstock & Richard J. O’Kennedy. (2013) A tale of two specificities: bispecific antibodies for therapeutic and diagnostic applications. Trends in Biotechnology 31:11, pages 621-632.
Crossref
Crossref
F. Mimoto, H. Katada, S. Kadono, T. Igawa, T. Kuramochi, M. Muraoka, Y. Wada, K. Haraya, T. Miyazaki & K. Hattori. (2013) Engineered antibody Fc variant with selectively enhanced Fc RIIb binding over both Fc RIIaR131 and Fc RIIaH131. Protein Engineering Design and Selection 26:10, pages 589-598.
Crossref
Crossref
Sonia Berrih-Aknin, Samia Ragheb, Rozen Le Panse & Robert P. Lisak. (2013) Ectopic germinal centers, BAFF and anti-B-cell therapy in myasthenia gravis. Autoimmunity Reviews 12:9, pages 885-893.
Crossref
Crossref
Tadeusz Robak. (2013) Emerging monoclonal antibodies and related agents for the treatment of chronic lymphocytic leukemia. Future Oncology 9:1, pages 69-91.
Crossref
Crossref
Ingrid Sassoon & Véronique Blanc. 2013. Antibody-Drug Conjugates. Antibody-Drug Conjugates
1
27
.